Rennova Health Inc (RNVA)

[nfrequent]

Keep your eye on the ball. Insider manipulation was the driver of almost all subpenny stock runs in the past. That ended September '21. Now, the OTC market has to consider the fundamentals, not just technical trading. That is a good thing, in fact the best thing, for RNVA after being oversold and artificially diluted by disproportionate short selling. The PE under 2 speaks for itself. The PE will be closer to 1 in this annual report. If you are an investor in RNVA, you are aruing against yourself. RNVA is poised to break out of the 000s and become the only game in town for technical traders.